Regeneron Pharmaceuticals Inc. buy Wells Fargo & Company
Start price
30.04.25
/
50%
€519.00
Target price
30.04.26
€615.65
Performance (%)
14.70%
End price
01.05.26
€595.30
Summary
This prediction ended on 01.05.26 with a price of €595.30. The BUY prediction by Wells_Fargo___Compan finished with a performance of 14.70%. Dividends of €3.58 are taken into consideration when calculating the performance. Wells_Fargo___Compan has 50% into this predictionRegeneron Pharmaceuticals, Inc. is a biotechnology company that is engaged in the discovery, development, and commercialization of medicines for the treatment of serious medical conditions. The company's products include EYLEA, a treatment for wet age-related macular degeneration and diabetic macular edema; Dupixent, a treatment for atopic dermatitis and asthma; and Libtayo, a treatment for certain types of cancer. Regeneron also has a strong focus on research and development, with a pipeline of potential new treatments for a variety of diseases. The company is headquartered in Tarrytown, New York and trades on the NASDAQ stock exchange under the symbol REGN.
Performance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Regeneron Pharmaceuticals Inc. | 0.113% | 0.113% | 19.611% |
| iShares Core DAX® | 1,35 % | 0,93 % | 6,81 % |
| iShares Nasdaq 100 | 3,28 % | 4,99 % | 41,20 % |
| iShares Nikkei 225® | 7,43 % | 16,60 % | 70,50 % |
| iShares S&P 500 | 1,70 % | 2,24 % | 27,28 % |
Comments by Wells_Fargo___Compan for this prediction
In the thread Regeneron Pharmaceuticals Inc. diskutieren
Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) had its price target lowered by analysts at Wells Fargo & Company from $750.00 to $700.00. They now have an "overweight" rating on the stock.
Ratings data for REGN provided by MarketBeat
In the thread Trading Regeneron Pharmaceuticals Inc.
Die von Wells_Fargo___Compan gewählte maximale Laufzeit wurde überschritten
Stopped prediction by Wells_Fargo___Compan for Regeneron Pharmaceuticals Inc.
Regeneron Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€693.60
10.01.25
10.01.25
€875.97
10.01.26
10.01.26
-1.53%
11.01.26
11.01.26
Regeneron Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€995.60
23.09.24
23.09.24
€1,078.7
23.09.25
23.09.25
-51.79%
24.09.25
24.09.25
Regeneron Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€992.60
02.08.24
02.08.24
€1,099.3
02.08.25
02.08.25
-51.42%
03.08.25
03.08.25